"Revolutionary Implant Offers Diabetes Relief with Insulin and Oxygen"
Researchers at MIT have developed an implantable insulin-producing bioreactor called the O2-Macrodevice, which uses electrolysis to generate oxygen for islet cells directly from the patient's own interstitial water. The implant successfully controlled blood glucose levels in diabetic mice, while mice who received an implant with the oxygen-generating cell disabled experienced hyperglycemia. The study authors are considering mass production of the cell chamber, indicating potential for commercial production. This innovative approach may offer a promising solution for treating type 1 diabetes.